A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine-Reference-Cited by-同舟云学术

A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine

Published:2019-03-08 Issue:3 Volume:45 Page:285-291
ISSN:0095-2990
Container-title:The American Journal of Drug and Alcohol Abuse
language:en
Short-container-title:The American Journal of Drug and Alcohol Abuse

Author:

Kelty Erin¹²^ORCID,Joyce David³,Hulse Gary¹

Affiliation:

1. Discipline of Psychiatry, University of Western Australia, Nedlands, Western Australian, Australia

2. School of Population and Global Health, University of Western Australia, Crawley, Western Australian, Australia

3. School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia

Funder

State Health Research Advisory Council

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/00952990.2018.1545131

Reference30 articles.

1. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies

2. An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam

3. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved

4. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study

5. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis;Drug and Alcohol Dependence;2024-03

2. Nurse Care Management for Opioid Use Disorder Treatment;JAMA Internal Medicine;2023-12-01

3. Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder;American Journal of Psychiatry;2023-05-01

4. Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder;Drug and Alcohol Dependence;2023-02

5. Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-09